Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2018 07:30 ET | Source: Theratechnologies

La FDA dégage Theratechnologies de ses obligations post-approbation en lien avec EGRIFTA(MD) (tésamoréline pour injection)

MONTRÉAL, 01 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui que la Food and Drug Administration (FDA) dégage Theratechnologies de ses...
May 01, 2018 07:30 ET | Source: Theratechnologies

FDA Releases Theratechnologies from Post-Approval Commitments Related to EGRIFTA® (Tesamorelin for Injection)

MONTREAL, May 01, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that the Food and Drug Administration (FDA) has released Theratechnologies from...
April 30, 2018 16:00 ET | Source: Theratechnologies

Le chef de la direction et le chef de la direction financière assisteront à la conférence d’investisseurs Bloom Burton à Toronto

MONTRÉAL, 30 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d’annoncer que Luc Tanguay, président et chef de la direction fera une présentation...
April 30, 2018 16:00 ET | Source: Theratechnologies

Theratechnologies’ CEO and CFO to Attend Bloom Burton Healthcare Investor Conference in Toronto

MONTREAL, April 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that Luc Tanguay, President and Chief Executive Officer will make a...
April 30, 2018 07:30 ET | Source: Theratechnologies

Theratechnologies Announces that Trogarzo(TM) (Ibalizumab-Uiyk) Injection is Now Available in the U.S.

MONTREAL, April 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that its novel antiretroviral TrogarzoTM is now commercially available in the...
April 30, 2018 07:30 ET | Source: Theratechnologies

Theratechnologies annonce que Trogarzo(MC) (ibalizumab-uiyk) injection est maintenant disponible aux États-Unis

MONTRÉAL, 30 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d’annoncer que son antirétroviral novateur TrogarzoMC est maintenant commercialement...
April 24, 2018 10:13 ET | Source: Theratechnologies

Theratechnologies déposera la demande d’approbation de Trogarzo(MC) (ibalizumab) en Europe

MONTRÉAL, 24 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui qu’elle entend déposer auprès de l’agence européenne des médicaments (AEM)...
April 24, 2018 10:13 ET | Source: Theratechnologies

Theratechnologies to Seek Regulatory Approval of Trogarzo™ (ibalizumab) in Europe

MONTREAL, April 24, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it will seek regulatory approval from the European Medicines Agency (EMA) for...
April 05, 2018 07:30 ET | Source: Theratechnologies

Theratechnologies annonce ses résultats financiers du premier trimestre de 2018

MONTRÉAL, 05 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd’hui ses résultats financiers pour le premier trimestre clos le 28 février...
April 05, 2018 07:30 ET | Source: Theratechnologies

Theratechnologies Announces Financial Results for First Quarter of 2018

MONTREAL, April 05, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced its financial results for the first quarter ended February 28, 2018. First quarter...